PROFOUND MEDICAL CORP. Earnings Per Share (Basic)
PROFOUND MEDICAL CORP. (PROF) reported Earnings Per Share (Basic) of -$0.26 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- PROFOUND MEDICAL CORP. earnings per share, basic for the quarter ending 2026-06-30 was -$0.26.
- PROFOUND MEDICAL CORP. earnings per share, basic for the quarter ending 2026-03-31 was $0.19, a 47.22% decline year-over-year.
- PROFOUND MEDICAL CORP. earnings per share, basic for the quarter ending 2025-12-31 was $2.52, a 28.03% increase year-over-year.
- PROFOUND MEDICAL CORP. earnings per share, basic for the quarter ending 2025-09-30 was $0.26, a 31.58% decline year-over-year.
- PROFOUND MEDICAL CORP. earnings per share, basic for fiscal 2025 was $1.41, a 25.89% increase from fiscal 2024.
- PROFOUND MEDICAL CORP. earnings per share, basic for fiscal 2024 was $1.12, a 16.42% decline from fiscal 2023.
- PROFOUND MEDICAL CORP. earnings per share, basic for fiscal 2023 was $1.34.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.26 10-Q · filed 2026-08-06 | -$0.46 10-Q · filed 2026-08-06 | $2.16 derived: net income ÷ weighted average shares · filed 2026-08-06 | $2.00 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2026-03-31 | $0.19 10-Q · filed 2026-05-07 | $2.51 derived: net income ÷ weighted average shares · filed 2026-05-07 | $2.35 derived: net income ÷ weighted average shares · filed 2026-05-07 | $1.90 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-12-31 | $2.52 derived: net income ÷ weighted average shares · filed 2026-03-05 | $2.27 derived: net income ÷ weighted average shares · filed 2026-03-05 | $1.76 derived: net income ÷ weighted average shares · filed 2026-08-06 | $1.41 10-K · filed 2026-03-05 | ||
| 2025-09-30 | $0.26 10-Q · filed 2025-11-13 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-08-06 | $1.14 10-Q · filed 2025-11-13 | $1.30 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-06-30 | -$0.52 10-Q · filed 2026-08-06 | $0.52 10-Q · filed 2025-08-14 | -$0.88 10-Q · filed 2026-08-06 | $0.88 10-Q · filed 2025-08-14 | $1.60 derived: net income ÷ weighted average shares · filed 2026-08-06 | $1.32 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | $0.36 10-Q · filed 2026-05-07 | $2.20 derived: net income ÷ weighted average shares · filed 2026-05-07 | $1.94 derived: net income ÷ weighted average shares · filed 2026-05-07 | $1.72 derived: net income ÷ weighted average shares · filed 2026-05-07 | ||
| 2024-12-31 | $1.97 derived: net income ÷ weighted average shares · filed 2026-03-05 | $1.64 derived: net income ÷ weighted average shares · filed 2026-03-05 | $1.38 derived: net income ÷ weighted average shares · filed 2026-03-05 | $1.12 10-K · filed 2026-03-05 | ||
| 2024-09-30 | $0.38 10-Q · filed 2025-11-13 | -$0.66 derived: net income ÷ weighted average shares · filed 2025-11-13 | $0.94 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $0.28 10-Q · filed 2025-08-14 | $0.55 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | $0.27 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | $1.34 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |